Med. praxi. 2022;19(2):109-114 | DOI: 10.36290/med.2022.015

Patient living with HIV in a general practitioner's outpatient clinic

MUDr. Sam Hofman, doc. MUDr. Dalibor Sedláček, CSc.
Klinika infekčních nemocí a cestovní medicíny Lékařské fakulty Univerzity Karlovy a Fakultní nemocnice Plzeň

HIV infection has been known for more than forty years. Over the course of four decades the disease has become in highly adherent patients treatable with a good prognosis, thanks to the tremendous efforts of many teams of scientists from around the world. Its diagnostic has been widely available since the mid-80s. Treatment has gone through many stages of development. Current approaches use combinations of several treatments blocking different sites in the HIV replication cycle. A properly treated patient should be in good clinical condition, the performance of his cellular immunity should be comparable to healthy individuals, and HIV RNA levels should be below the detection capabilities of the method used (usually PCR) for a long time. A patient treated in this way has a great chance of living to approximately the same age as an HIV-negative peer. Thanks to long-term proper treatment, people living with HIV live much longer than before and develop diseases typical of an aging population. The treatment of these comorbidities often requires an interdisciplinary approach, where an important unifying function is undoubtedly ensured by the general practitioner.

Keywords: AIDS, antiretroviral therapy, HIV, PLWH, HIV RNA.

Published: May 5, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hofman S, Sedláček D. Patient living with HIV in a general practitioner's outpatient clinic. Med. praxi. 2022;19(2):109-114. doi: 10.36290/med.2022.015.
Download citation

References

  1. Ryom L, de Miguel R, Cotter AG, et al. EACS Governing Board. Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021. HIV Med. 2022 Mar 25. doi: 10.1111/hiv.13268. Epub ahead of print. PMID: 35338549. Go to original source... Go to PubMed...
  2. Snopková S, Rozsypal H, Aster V, et al. Doporučený postup péče o dospělé infikované HIV a postexpoziční profylaxe infekce HIV. Available from: https://www.infekce.cz/DPHIV19.htm.
  3. Wandeler G, Johnson LF, Egger M. Trends in life expectancy of HIV­‑positive adults on ART across the globe: comparisons with general population. Curr Opin HIV AIDS. 2016;11(5):492-500. doi:10.1097/COH.0000000000000298. Go to original source... Go to PubMed...
  4. Global HIV and AIDS statistics - 2020 fact sheet. UNAIDS. Accessed March 10, 2021. Available from: https://www.unaids.org/en/resources/fact­‑sheet.
  5. Shaw GM, Hunter E. HIV Transmission. Cold Spring Harb Perspect Med. 2012;2:a006965. doi: 10.1101/cshperspect.a006965. Go to original source... Go to PubMed...
  6. Churchill MJ, Deeks SG, Margolis DM, et al. HIV reservoirs: what, where and how to target them. Nature Reviews Microbiology. 2016;14:55-60. Go to original source... Go to PubMed...
  7. Malstan T, Xanthopoulou AM, Terzi I, et al. Late Presenters of HIV Infection in an HIV Unit of a Tertiary University Hospital in a Rural Region of Greece. AIDS Res Hum Retroviruses. 2020;36(7):601-605. Go to original source... Go to PubMed...
  8. Rodger AJ, Cambiano V, Bruun T, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV­‑positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019;393:2428-2438. Available from: http://dx.doi.org/10.1016/ S0140-6736(19)30418-0. Go to original source... Go to PubMed...
  9. Bor J, Fischer Ch, Modi M, et al. Changing Knowledge and Attitudes Towards HIV TreatmentasPrevention and "Undetectable=Untransmittable": A Systematic Review. AIDS and Behavior. 2021;25:4209-4224. Available from: https://doi.org/10.1007/s10461-021-03296-8. Go to original source... Go to PubMed...
  10. Sultan B, Benn P, Waters L. Current perspectives in HIV post­‑exposure prophylaxis. HIV/AIDS-Research and Palliative Care. 2014;6:147-158. Go to original source... Go to PubMed...
  11. Eakle R, Venter F, Rees H. Pre­‑exposure prophylaxis (PrEP) in an era of stalled HIV prevention: Can it change the game? Retrovirology. 2018;15:29. Available from: https://doi.org/10.1186/s12977-018-0408-3. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.